Societe de Promotion Pharmaceutique du Maghreb S.A. (CBSE:PRO)
Morocco
· Delayed Price · Currency is MAD 1,430.00
0.00 (0.00%)
At close: Mar 4, 2026
CBSE:PRO Revenue
Societe de Promotion Pharmaceutique du Maghreb had revenue of 464.22M MAD in the half year ending June 30, 2025, with 27.27% growth. This brings the company's revenue in the last twelve months to 928.99M, up 11.80% year-over-year. In the year 2024, Societe de Promotion Pharmaceutique du Maghreb had annual revenue of 898.71M with 11.57% growth.
Revenue (ttm)
928.99M
Revenue Growth
+11.80%
P/S Ratio
1.54
Revenue / Employee
2.71M
Employees
343
Market Cap
1.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 898.71M | 93.20M | 11.57% |
| Dec 31, 2023 | 805.52M | 100.88M | 14.32% |
| Dec 31, 2022 | 704.64M | 74.15M | 11.76% |
| Dec 31, 2021 | 630.49M | 57.30M | 10.00% |
| Dec 31, 2020 | 573.20M | 50.75M | 9.71% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Microdata | 849.58M |
| Colorado | 612.39M |
| Agma SA | 180.79M |
| Dari Couspate | 858.92M |
| Salafin | 678.23M |
| Société Maghrébine de Crédit-bail | 3.94B |
| Disway | 2.01B |
| AFMA S.A. | 304.74M |